Neural stem cells (NSC) also showed promising potential in delivering Ad5-based oncolytic CRAd-Survivin-pk7 in treating brain cancer, especially glioblastoma multiforme (GBM) [29,30,31,32,33,34,35]. The gene discussed is BIRC5; the disease is glioblastoma.